Virtu Financial LLC bought a new stake in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 20,697 shares of the company's stock, valued at approximately $579,000.
A number of other hedge funds have also recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. grew its holdings in shares of Confluent by 2.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,284,037 shares of the company's stock valued at $46,549,000 after buying an additional 64,926 shares during the last quarter. Cerity Partners LLC raised its stake in shares of Confluent by 28.1% in the third quarter. Cerity Partners LLC now owns 35,129 shares of the company's stock worth $716,000 after purchasing an additional 7,705 shares during the last quarter. Algert Global LLC purchased a new position in shares of Confluent in the third quarter worth $1,775,000. Qsemble Capital Management LP lifted its holdings in shares of Confluent by 195.7% during the third quarter. Qsemble Capital Management LP now owns 118,994 shares of the company's stock valued at $2,425,000 after purchasing an additional 78,746 shares in the last quarter. Finally, Quantbot Technologies LP boosted its position in shares of Confluent by 1,465.6% during the third quarter. Quantbot Technologies LP now owns 30,295 shares of the company's stock valued at $617,000 after buying an additional 28,360 shares during the last quarter. 78.09% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of analysts have recently issued reports on CFLT shares. Truist Financial raised their price target on shares of Confluent from $35.00 to $40.00 and gave the company a "buy" rating in a report on Wednesday, February 12th. Stifel Nicolaus lifted their target price on shares of Confluent from $37.00 to $40.00 and gave the stock a "buy" rating in a research report on Wednesday, February 12th. Canaccord Genuity Group increased their price target on Confluent from $34.00 to $38.00 and gave the company a "buy" rating in a report on Wednesday, February 12th. UBS Group raised Confluent from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $34.00 to $38.00 in a report on Wednesday, February 26th. Finally, Bank of America increased their target price on Confluent from $26.00 to $31.00 and gave the company an "underperform" rating in a report on Wednesday, February 12th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $35.33.
Read Our Latest Report on Confluent
Confluent Price Performance
NASDAQ CFLT traded down $1.24 on Friday, reaching $24.33. The company had a trading volume of 4,455,044 shares, compared to its average volume of 4,364,834. The stock has a market capitalization of $8.13 billion, a PE ratio of -22.53 and a beta of 0.90. Confluent, Inc. has a 12 month low of $17.79 and a 12 month high of $37.90. The company has a quick ratio of 4.24, a current ratio of 3.99 and a debt-to-equity ratio of 1.14. The firm's 50 day moving average price is $29.36 and its 200 day moving average price is $27.20.
Confluent (NASDAQ:CFLT - Get Free Report) last issued its earnings results on Tuesday, February 11th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.28). Confluent had a negative return on equity of 34.70% and a negative net margin of 35.81%. As a group, equities analysts predict that Confluent, Inc. will post -0.83 earnings per share for the current year.
Insider Buying and Selling
In other Confluent news, CEO Edward Jay Kreps sold 232,500 shares of Confluent stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $32.33, for a total value of $7,516,725.00. Following the completion of the transaction, the chief executive officer now directly owns 452,488 shares of the company's stock, valued at $14,628,937.04. This trade represents a 33.94 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CAO Kong Phan sold 6,346 shares of the business's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $36.22, for a total transaction of $229,852.12. Following the completion of the sale, the chief accounting officer now owns 179,593 shares in the company, valued at approximately $6,504,858.46. This trade represents a 3.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,200,746 shares of company stock worth $38,505,150. Insiders own 13.82% of the company's stock.
Confluent Company Profile
(
Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Read More

Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.